Goodwin advised Sage Therapeutics on the transaction Sage Therapeutics (NASDAQ:SAGE) executed the pricing of an underwritten public offering of 3,506,098 shares of its common stock at…
Sage Therapeutics’ $575 Million Public Offering of Common Stock
Goodwin advised Sage Therapeutics on the transaction Sage Therapeutics (NASDAQ:SAGE) executed the pricing of an underwritten public offering of 3,506,098 shares of its common stock at…